FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to dentistry. Enterosorbent Lactofiltrum is taken orally twice a year, in spring in March and in autumn in September, 4 times a day: three times a day one hour before meals and additionally at night in an age dosage for 4–5 days.
EFFECT: invention provides achieving stable remission of erythema multiforme.
1 cl, 5 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR TREATMENT OF ULCERNECROTIC INJURE OF MUCOUS MEMBRANE OF ORAL CAVITY | 0 |
|
SU1155267A1 |
| METHOD OF PREDICTING TYPE OF COURSE OF LICHEN PLANUS OF ORAL MUCOSA | 2022 |
|
RU2812602C2 |
| METHOD FOR TREATING TUMOR DISEASES OF FACE SKIN AND ORAL CAVITY MUCOSA WITH LASER RADIATION | 1994 |
|
RU2101045C1 |
| METHOD OF TREATMENT OF ALLERGIC DERMATOSES | 0 |
|
SU1404079A1 |
| DEVICE FOR TREATMENT OF INFLAMMATORY DISEASES OF THE ORAL MUCOSA | 2017 |
|
RU2663327C1 |
| METHOD OF ENTERAL DETOXIFICATION ACCOMPANYING TREATING IMMUNE DISORDERS | 2011 |
|
RU2455012C1 |
| COMPOSITION FOR TREATMENT OF MOUTH CAVITY SICKNESSES | 1998 |
|
RU2137461C1 |
| MEANS AND METHOD FOR TREATING INFLAMMATORY DISEASES OF MUCOUS MEMBRANE IN ORAL CAVITY | 2005 |
|
RU2290918C1 |
| METHOD OF TREATMENT OF CHRONIC RECURRENT APHTHOUS STOMATITIS | 2023 |
|
RU2806004C1 |
| METHOD OF TREATING INFLAMMATORY PERIODONTAL AND ORAL MUCOSAL DISEASES | 2014 |
|
RU2552307C1 |
